Abstract
purpose. To investigate the expression and function of toll-like receptor (TLR)-3 and -9 in corneal myofibroblasts.
methods. Two types of human keratocytes were used, which were freshly isolated keratocytes from donor corneas and cultured keratocytes. Expression of the mRNAs for various molecular markers was analyzed in these cells by RT-PCR, and TLR-2, -3, -4, and -9 mRNAs were also analyzed by RT-PCR. Expression of TLR-3 and -9 at the protein level was assessed by flow cytometry. In addition, an antibody array and ELISA were used to detect chemokines and cytokines in the supernatant of cultured keratocytes, with or without stimulation by poly inosine-polycytidylic acid (poly (I:C)) or CpG-DNA. Furthermore, a phagocytosis assay was performed to evaluate whether signaling via TLR-3 and -9 enhances phagocytosis.
results. Keratocytes cultured for three passages underwent differentiation into corneal myofibroblasts. TLR-3 and -9 were detected in corneal myofibroblasts at the mRNA and protein levels, but not in freshly isolated keratocytes. Stimulation of corneal myofibroblasts with poly (I:C) or CpG-DNA enhanced the production of IL-6, IL-8, GRO, ENA-78, and RANTES compared with that by untreated cells. Phagocytic activity of myofibroblasts was upregulated by signaling via TLR-3 and -9.
conclusions. This is the first report on the in vitro expression and function of TLR-3 and -9 in corneal myofibroblasts. The findings suggest that the keratocyte phenotype determines the expression of TLR-3 and -9 and that corneal myofibroblasts may have an important role in bacterial and viral clearance.
The corneal epithelium is the first line of defense against invading organisms. Physical or chemical injury of the cornea can impair the integrity of this epithelial barrier, allowing the entry of organisms and microbial products into the underlying epithelium and the stroma. The corneal stroma consists of abundant extracellular populations of keratocytes and is the second line of defense against invading organisms. In normal corneal tissue, keratocytes are quiescent cells that are derived from the neural crest and have a flattened and stellate morphology. When the integrity of the corneal stroma is disrupted, these quiescent keratocytes differentiate into fibroblasts and/or myofibroblasts, which then proliferate, migrate to the site of injury, and repair the stroma.
1 2 3 4 5 6 7 Corneal myofibroblasts differ from keratocytes with respect to morphology, proliferation rate, phagocytic activity, extracellular matrix production, and the expression of various gene products such as CD34, keratocan, and α-smooth muscle actin (α-SMA).
8 9 10 11 12 13 14 15 16 17 18 The myofibroblast phenotype is defined by both the shape of these cells and the detection of α-SMA in the cytoplasm. It is well known that fibroblasts/myofibroblasts have a crucial role in corneal defenses. For example, corneal myofibroblasts can engulf bacteria and other foreign bodies, and Lande et al.
19 reported that human corneal myofibroblasts show significantly more phagocytic activity than do human skin fibroblasts or rabbit chondrocytes. Corneal myofibroblasts also promote contraction of the extracellular matrix after the integrity of the corneal stroma is disrupted.
20 These findings suggest that the phagocytic and contractile properties of corneal fibroblasts/myofibroblasts may be involved in the initial response of this avascular tissue to invading organisms. Recently, Kumagai et al.
21 demonstrated that cultured corneal fibroblasts/myofibroblasts expressed mRNA for toll-like receptor (TLF)-4, which is a receptor for lipopolysaccharide (LPS) produced by Gram-negative bacteria. Stimulation with LPS increases the production of IL-8 and monocyte chemotactic protein (MCP)-I by corneal fibroblasts/myofibroblasts. Accordingly, corneal fibroblasts and myofibroblasts may play an important role in corneal defenses by recognizing LPS and producing chemokines that attract leukocytes.
Although the human TLRs were discovered only 15 years ago, these receptors have since been found to occupy center stage in the innate immune response to invading pathogens.
22 To date, at least 12 TLRs (TLR-1 to -12) have been described. Each TLR acts as the primary sensor of conserved microbial components and drives the induction of specific biological responses.
23 24 25 For example, peptidoglycan, lipopolysaccharide, and flagellin are recognized by TLR-2, -4, and -5, respectively,
22 25 whereas TLR-3 is involved in the recognition of viral components like double-stranded RNA (dsRNA) and poly (I:C) (poly inosine-polycytidylic acid).
26 27 28 In addition, TLR-7 and -8 are involved in the recognition of single-stranded RNA (ssRNA) viruses and ssRNA,
29 30 31 whereas TLR-9 recognizes viral and bacterial DNA that has not been methylated at CpG motifs.
22 24 32 33 34 35 Recently, Johnson et al.
36 demonstrated that the corneal epithelium expresses functional TLR-9. Activation of TLR-9 stimulates neutrophil recruitment to the corneal stroma in mice and causes a significant increase in corneal thickness and opacity. In addition, Huang et al.
37 have shown that signaling via TLR-9 is important in
P. aeruginosa keratitis and in the clearance of bacteria from the cornea. These two reports suggest that TLR-9 has a crucial role in fighting bacterial infection of the cornea. However, there have been no in vitro investigations into the expression and function of TLR-9 in keratocytes or corneal myofibroblasts. To our knowledge, the expression and function of TLR-3 in keratocytes or corneal myofibroblasts also has not been studied. Therefore, we performed the present study to investigate the in vitro expression and function of TLR-3 and -9 in keratocytes and corneal myofibroblasts.
Mouse anti-human TLR-3 monoclonal antibody (mAb; IgG1) was purchased from HyCult Biotechnology b.v. (Uden, The Netherlands) and mouse anti-human TLR-9 mAb (clone 26C593; IgG1) from Oncogene Research Products (San Diego, CA). These mAbs were used for flow cytometry. A TLR-3 agonist, poly (I:C), was obtained from Calbiochem (La Jolla, CA), and two TLR-9 agonists (CpG-DNA motifs and non-CpG-DNA motifs) were purchased from HyCult Biotechnology b.v.
Total RNA was obtained from freshly isolated keratocytes and cultured keratocytes (TRIzol; Invitrogen, San Diego, CA). Reverse transcription was performed (SuperScript First-Strand Synthesis System; Invitrogen). Approximately 0.3 μg of total RNA was used in each reverse transcription reaction. Amplification was performed in a final volume of 20 μL using 5 U/μL of
Taq DNA polymerase, 10× PCR buffer (Mg
2+ free), 50 mM MgCl
2, 10 mM dNTP mix, and 10 μM of each primer
(Table 1) . The PCR reaction involved initial denaturation at 94°C for 2 minutes, followed by denaturation at 94°C for 60 seconds, annealing at 54°C and 60°C for 60 seconds, and elongation at 72°C for 60 seconds The reaction was continued for 30 to 35 cycles and was completed by extended elongation at 72°C for 10 minutes After PCR amplification, 10 μL of each PCR product was subjected to electrophoresis on 1.5% agarose gel and the gel was stained with ethidium bromide (0.5 mg/mL). The PCR primers are listed in
Table 1 . These primers were selected to discriminate between cDNA and genomic DNA by using specific primers for different exons. The amount of cDNA obtained from freshly isolated or cultured keratocytes was adjusted relative to the band density of glyceraldehyde-3-phosphate dehydrogenase (G3PDH). The amplification curve of the PCR products was drawn from data obtained at four-cycle intervals. Within the linear range of amplification, band densities were compared between different treatments of the keratocytes.
G3PDH and human TLR-2, -3, or -4 dual PCR kits (Maxim; Biotech, Inc. South San Francisco, CA) were used to detect TLR-2, -3, and -4 mRNA in keratocytes or corneal myofibroblasts, respectively, according to the manufacturer’s instructions. In the dual PCR system, each target gene was coamplified with a specific housekeeping gene to achieve quantitative amplification in a single tube without interfering with the expression of target genes. A human toll-like receptor-9 primer set kit (Maxim, Biotech Inc.) was used to detect TLR-9 mRNA in keratocytes or corneal myofibroblasts. The primer for TLR-3 yielded a 431-bp product and the primer for G3PDH gave a 563-bp product, while the products for TLR-9, -2, and -4 were 260, 302, and 631 bp, respectively.
To detect the expression of TLR-3 and -9 protein in corneal myofibroblasts, we used flow cytometry (FACScan; BD Biosciences, San Jose, CA). After they were washed with buffer (FACS PBS [pH 7.4], 0.5% BSA, and 0.02% sodium azide), 106 cells were treated with Fc-block (BD Biosciences) for 15 minutes and then were incubated with mAbs targeting human TLR-3 or -9 or with isotype control mouse IgG (BD-PharMingen, San Diego, CA) for 1 hour at room temperature. Cells were then washed twice with the buffer and incubated for 30 minutes with FITC-conjugated anti-mouse IgG (BD PharMingen). Finally, the cells were washed twice more with the buffer and analyzed. To gate out dead cells, staining with a kit containing propidium iodide (PI) was performed according to the manufacturer’s instructions (BD Biosciences). For analysis of intracellular expression, a cell fixation-permeabilization kit (BD PharMingen) was used. Cells were fixed (Cytofix/Cytoperm; BD Biosciences) and then stained with the respective mAbs. Data were analyzed with the accompanying software (Cell Quest; BD Biosciences).
The conditioned medium obtained from cultures of corneal myofibroblasts was analyzed with an antibody array (Ray Bio; Human Angiogenesis Antibody I kit; RayBiotech Inc., Norcross, GA) according to the manufacturer’s instructions.
This kit could simultaneously detect 20 different factors, including chemokines, cytokines, soluble cytokine receptors, and growth factors.
The antibody array was placed into an eight-well tray, washed twice with Tris-buffered saline, and incubated for 30 minutes at room temperature with 2 mL/well of 1× blocking buffer. Then, 1 mL of supernatant from the myofibroblasts cultured in a six-well plate (35 mm in diameter) was added to each array and incubation was performed overnight at 4°C. After the samples were decanted, the antibody arrays were washed three times (for 5 minutes each) with 2 mL of 1× washing buffer I at room temperature, followed by washing twice (for 5 minutes each) with 1× washing buffer II at room temperature. Then, 1 mL of a 1:250 dilution of biotinylated antibody was added to each array and was incubated overnight at 4°C with shaking. After further washing, the array was incubated for 1 hour at room temperature with 2 mL/well of a 1:1000 dilution of HRP-conjugated streptavidin. After a thorough washing, each membrane was incubated at room temperature for 5 minutes with a mixture of 1× detection buffers C and D. The arrays were then exposed to autoradiograph film (BioMax Light film; Eastman Kodak, Tokyo, Japan) for 1 minute before processing. The signal intensity of individual spots was determined by densitometry with analyzer software (Gel-Pro; Media Cybernetics, Inc., Silver Spring, MD).
Cytokine and chemokine production by cells incubated with or without CpG-DNA or poly (I:C) stimulation was detected after the cells had been washed twice with PBS and cultured in serum-free DMEM. The culture supernatant was harvested after 24 hours of incubation and was analyzed by using the antibody array.
To detect growth-related oncogene (GRO), IL-6, IL-8, regulated on activation, normal, T-cell–expressed and secreted (RANTES), and epithelial cell-derived neutrophil activating peptide (ENA)-78 in the conditioned medium of corneal myofibroblasts, we used ELISA kits according to the manufacturer’s instructions (Quantikine; R&D Systems, Minneapolis, MN). Corneal myofibroblasts were grown to subconfluence in DMEM with 10% FCS, washed twice with PBS, and then incubated in serum-free DMEM basal medium for 24 hours with or without exposure to poly (I:C) or CpG-DNA or non-CpG-DNA. Then, the supernatant was harvested for analysis by ELISA.
To determine the influence of TLR-3 and -9 on phagocytosis, we pretreated corneal myofibroblasts with poly (I:C) or CpG DNA and measured the uptake of fluorescein-conjugated particles derived from Escherichia coli (K-12 strain; Invitrogen). The phagocytosis assay was performed with a kit (Vybrant; Invitrogen), according to the manufacturer’s instructions, and was performed in serum-free medium, to eliminate the contribution of Fc and/or complement receptors. Corneal myofibroblasts were washed twice in serum-free medium without antibiotics before being challenged with the particles. The optimum time for measurement of phagocytosis was determined to be 45 minutes after particle challenge. At this time, the myofibroblasts were washed with cold PBS to stop additional particle uptake or destruction of particles in the phagolysosomes. Finally, the fluorescence intensity of the myofibroblasts was estimated with a fluorescence plate reader (Fluoroskan-Ascent; Labsystems, Vantaa, Finland).
Expression of TLR-2, -3, -4, and -9 mRNAs by Freshly Isolated Keratocytes and Corneal Myofibroblasts
Chemokine Production in Corneal Myofibroblasts Detected by Antibody Array Analysis